Cargando…
One-year monitoring of an oligonucleotide fluorescence in situ hybridization probe panel laboratory-developed test for bladder cancer detection
BACKGROUND: Previously, we had developed and manufactured an oligonucleotide fluorescence in situ hybridization (OligoFISH) probe panel based on the most clinically sensitive chromosomes found in a reference set of bladder carcinoma cases. The panel was clinically validated for use as a diagnostic a...
Autores principales: | Tinawi-Aljundi, Rima, King, Lauren, Knuth, Shannon T, Gildea, Michael, Ng, Carrie, Kahl, Josh, Dion, Jacqueline, Young, Chris, Schervish, Edward W, Frontera, J Rene, Hafron, Jason, Kernen, Kenneth M, Di Loreto, Robert, Aurich-Costa, Joan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399392/ https://www.ncbi.nlm.nih.gov/pubmed/25914883 http://dx.doi.org/10.2147/RRU.S79085 |
Ejemplares similares
-
Minimally invasive prostate cancer detection test using FISH probes
por: Tinawi-Aljundi, Rima, et al.
Publicado: (2016) -
Evaluation of an RNAseq-Based Immunogenomic Liquid Biopsy Approach in Early-Stage Prostate Cancer
por: Van Neste, Leander, et al.
Publicado: (2021) -
A comparison of alternative 60-mer probe designs in an in-situ synthesized oligonucleotide microarray
por: Leiske, Danielle L, et al.
Publicado: (2006) -
Chorus2: design of genome‐scale oligonucleotide‐based probes for fluorescence in situ hybridization
por: Zhang, Tao, et al.
Publicado: (2021) -
National Cancer Database Comparison of Radical Cystectomy vs Chemoradiotherapy for Muscle‐Invasive Bladder Cancer: Implications of Using Clinical vs Pathologic Staging
por: Lin, Hong‐Yiou, et al.
Publicado: (2018)